$BMTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMIMETIC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMIMETIC THERAPEUTICS, INC.. Get notifications about new insider transactions in BIOMIMETIC THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.87 | 400 | 2,748 | 28,668 | 28.3 K to 28.7 K (+1.42 %) |
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.86 | 600 | 4,116 | 28,268 | 27.7 K to 28.3 K (+2.17 %) |
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.80 | 4,400 | 29,920 | 27,668 | 23.3 K to 27.7 K (+18.91 %) |
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.75 | 200 | 1,350 | 23,268 | 23.1 K to 23.3 K (+0.87 %) |
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.73 | 200 | 1,346 | 23,068 | 22.9 K to 23.1 K (+0.87 %) |
Apr 01 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 6.72 | 200 | 1,344 | 22,868 | 22.7 K to 22.9 K (+0.88 %) |
Mar 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 8.45 | 1,200 | 10,140 | 16,099 | 17.3 K to 16.1 K (-6.94 %) |
Mar 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | A | 8.54 | 35,000 | 298,900 | 35,000 | |
Mar 02 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 8.54 | 30,000 | 256,200 | 30,000 | |
Mar 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Hirsch Steven Neal | COO & Executive VP | Option Exercise | A | 8.54 | 60,000 | 512,400 | 60,000 | |
Mar 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Option Exercise | A | 8.54 | 35,000 | 298,900 | 35,000 | |
Mar 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | A | 8.54 | 80,000 | 683,200 | 80,000 | |
Feb 17 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 1,000 | 0 | 5,350 | 4.4 K to 5.4 K (+22.99 %) |
Feb 17 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 1,000 | 0 | 9,300 | 10.3 K to 9.3 K (-9.71 %) |
Feb 17 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
Feb 17 2009 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 2,000 | 0 | 22,668 | 24.7 K to 22.7 K (-8.11 %) |
Jan 30 2009 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 9.63 | 50,000 | 481,440 | 3,376,659 | 3.3 M to 3.4 M (+1.50 %) |
Jan 29 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.63 | 50,000 | 481,440 | 1,213,811 | 1.3 M to 1.2 M (-3.96 %) |
Dec 30 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 2,750 | 0 | 4,350 | 1.6 K to 4.4 K (+171.88 %) |
Dec 30 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
Dec 30 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 1,250 | 0 | 2,050 | 800 to 2.1 K (+156.25 %) |
Dec 30 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 1,250 | 0 | 2,050 | 800 to 2.1 K (+156.25 %) |
Dec 30 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Gift | G | 0.00 | 6,500 | 0 | 10,300 | 16.8 K to 10.3 K (-38.69 %) |
Nov 13 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 8.00 | 500 | 4,000 | 3,326,659 | 3.3 M to 3.3 M (+0.02 %) |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | M | 0.67 | 7,500 | 5,025 | 0 | |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | M | 0.67 | 7,500 | 5,025 | 16,800 | 9.3 K to 16.8 K (+80.65 %) |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | M | 3.63 | 26,250 | 95,288 | 26,250 | |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | M | 3.47 | 51,000 | 176,970 | 0 | |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | M | 3.63 | 26,250 | 95,288 | 1,263,811 | 1.2 M to 1.3 M (+2.12 %) |
Oct 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | M | 3.47 | 51,000 | 176,970 | 1,237,561 | 1.2 M to 1.2 M (+4.30 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.60 | 597 | 6,328 | 3,325,387 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.59 | 300 | 3,177 | 3,324,790 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.58 | 303 | 3,206 | 3,324,490 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.56 | 100 | 1,056 | 3,324,187 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.55 | 2,100 | 22,155 | 3,324,087 | 3.3 M to 3.3 M (+0.06 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.54 | 600 | 6,324 | 3,321,987 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.53 | 700 | 7,371 | 3,321,387 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.51 | 100 | 1,051 | 3,320,687 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.50 | 104 | 1,092 | 3,320,587 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.48 | 1,796 | 18,822 | 3,320,483 | 3.3 M to 3.3 M (+0.05 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.47 | 500 | 5,235 | 3,318,687 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.46 | 2,500 | 26,150 | 3,318,187 | 3.3 M to 3.3 M (+0.08 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.45 | 100 | 1,045 | 3,315,687 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.44 | 1,571 | 16,401 | 3,315,587 | 3.3 M to 3.3 M (+0.05 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.42 | 429 | 4,470 | 3,314,016 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.40 | 400 | 4,160 | 3,313,587 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.39 | 300 | 3,117 | 3,313,187 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.38 | 100 | 1,038 | 3,312,887 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.37 | 600 | 6,222 | 3,312,787 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.36 | 1,200 | 12,432 | 3,312,187 | 3.3 M to 3.3 M (+0.04 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.35 | 700 | 7,245 | 3,310,987 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.34 | 300 | 3,102 | 3,310,287 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.33 | 1,000 | 10,330 | 3,309,987 | 3.3 M to 3.3 M (+0.03 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.32 | 600 | 6,192 | 3,308,987 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.31 | 300 | 3,093 | 3,308,387 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.30 | 100 | 1,030 | 3,308,087 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.29 | 200 | 2,058 | 3,307,987 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.28 | 400 | 4,112 | 3,307,787 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.27 | 800 | 8,216 | 3,307,387 | 3.3 M to 3.3 M (+0.02 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.26 | 600 | 6,156 | 3,306,587 | 3.3 M to 3.3 M (+0.02 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.50 | 1,500 | 15,750 | 3,305,987 | 3.3 M to 3.3 M (+0.05 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.48 | 1,300 | 13,624 | 3,304,487 | 3.3 M to 3.3 M (+0.04 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.43 | 100 | 1,043 | 3,303,187 | 3.3 M to 3.3 M (0.00 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.42 | 400 | 4,168 | 3,303,087 | 3.3 M to 3.3 M (+0.01 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.40 | 100 | 1,040 | 3,302,687 | 3.3 M to 3.3 M (0.00 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.39 | 500 | 5,195 | 3,302,587 | 3.3 M to 3.3 M (+0.02 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.38 | 400 | 4,152 | 3,302,087 | 3.3 M to 3.3 M (+0.01 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.37 | 900 | 9,333 | 3,301,687 | 3.3 M to 3.3 M (+0.03 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.36 | 1,600 | 16,576 | 3,300,787 | 3.3 M to 3.3 M (+0.05 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.35 | 299 | 3,095 | 3,299,187 | 3.3 M to 3.3 M (+0.01 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.34 | 163 | 1,685 | 3,298,888 | 3.3 M to 3.3 M (0.00 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.33 | 970 | 10,020 | 3,298,725 | 3.3 M to 3.3 M (+0.03 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.32 | 1,124 | 11,600 | 3,297,755 | 3.3 M to 3.3 M (+0.03 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.31 | 1,230 | 12,681 | 3,296,631 | 3.3 M to 3.3 M (+0.04 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.30 | 2,682 | 27,625 | 3,295,401 | 3.3 M to 3.3 M (+0.08 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.29 | 2,570 | 26,445 | 3,292,719 | 3.3 M to 3.3 M (+0.08 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.28 | 1,930 | 19,840 | 3,290,149 | 3.3 M to 3.3 M (+0.06 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.27 | 700 | 7,189 | 3,288,219 | 3.3 M to 3.3 M (+0.02 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.26 | 2,300 | 23,598 | 3,287,519 | 3.3 M to 3.3 M (+0.07 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.25 | 700 | 7,175 | 3,285,219 | 3.3 M to 3.3 M (+0.02 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.24 | 1,800 | 18,432 | 3,284,519 | 3.3 M to 3.3 M (+0.05 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.23 | 1,300 | 13,299 | 3,282,719 | 3.3 M to 3.3 M (+0.04 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.21 | 100 | 1,021 | 3,281,419 | 3.3 M to 3.3 M (0.00 %) |
Sep 09 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.20 | 32 | 326 | 3,281,319 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.47 | 172 | 1,801 | 3,326,159 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.66 | 185 | 1,972 | 3,325,987 | 3.3 M to 3.3 M (+0.01 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.65 | 100 | 1,065 | 3,325,802 | 3.3 M to 3.3 M (0.00 %) |
Sep 10 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.63 | 315 | 3,348 | 3,325,702 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 11.00 | 200 | 2,200 | 3,281,287 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.93 | 200 | 2,186 | 3,281,087 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.91 | 200 | 2,182 | 3,280,887 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.83 | 100 | 1,083 | 3,280,687 | 3.3 M to 3.3 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.68 | 200 | 2,136 | 3,280,587 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.66 | 300 | 3,198 | 3,280,387 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.62 | 200 | 2,124 | 3,280,087 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.61 | 200 | 2,122 | 3,279,887 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.59 | 200 | 2,118 | 3,279,687 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.58 | 400 | 4,232 | 3,279,487 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.57 | 2,700 | 28,539 | 3,279,087 | 3.3 M to 3.3 M (+0.08 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.56 | 400 | 4,224 | 3,276,387 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.55 | 800 | 8,440 | 3,275,987 | 3.3 M to 3.3 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.54 | 2,000 | 21,080 | 3,275,187 | 3.3 M to 3.3 M (+0.06 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.53 | 1,800 | 18,954 | 3,273,187 | 3.3 M to 3.3 M (+0.06 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.53 | 200 | 2,105 | 3,271,387 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.52 | 1,600 | 16,832 | 3,271,187 | 3.3 M to 3.3 M (+0.05 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.52 | 100 | 1,052 | 3,269,587 | 3.3 M to 3.3 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.51 | 4,069 | 42,765 | 3,269,487 | 3.3 M to 3.3 M (+0.12 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.51 | 100 | 1,051 | 3,265,418 | 3.3 M to 3.3 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.50 | 3,200 | 33,600 | 3,265,318 | 3.3 M to 3.3 M (+0.10 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.49 | 2,637 | 27,662 | 3,262,118 | 3.3 M to 3.3 M (+0.08 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.48 | 1,294 | 13,561 | 3,259,481 | 3.3 M to 3.3 M (+0.04 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.47 | 63 | 660 | 3,258,187 | 3.3 M to 3.3 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.46 | 400 | 4,184 | 3,258,124 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.44 | 300 | 3,132 | 3,257,724 | 3.3 M to 3.3 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.43 | 900 | 9,387 | 3,257,424 | 3.3 M to 3.3 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.42 | 1,680 | 17,506 | 3,256,524 | 3.3 M to 3.3 M (+0.05 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.41 | 4,300 | 44,763 | 3,254,844 | 3.3 M to 3.3 M (+0.13 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.40 | 22,317 | 232,097 | 3,250,544 | 3.2 M to 3.3 M (+0.69 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.40 | 2,810 | 29,210 | 3,228,227 | 3.2 M to 3.2 M (+0.09 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.39 | 800 | 8,312 | 3,225,417 | 3.2 M to 3.2 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.39 | 100 | 1,039 | 3,224,617 | 3.2 M to 3.2 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.38 | 2,757 | 28,618 | 3,224,517 | 3.2 M to 3.2 M (+0.09 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.38 | 400 | 4,150 | 3,221,760 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.37 | 5,337 | 55,345 | 3,221,360 | 3.2 M to 3.2 M (+0.17 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.37 | 1,700 | 17,621 | 3,216,023 | 3.2 M to 3.2 M (+0.05 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.36 | 7,195 | 74,540 | 3,214,323 | 3.2 M to 3.2 M (+0.22 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.36 | 100 | 1,036 | 3,207,128 | 3.2 M to 3.2 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.35 | 800 | 8,280 | 3,207,028 | 3.2 M to 3.2 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.34 | 921 | 9,523 | 3,206,228 | 3.2 M to 3.2 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.33 | 1,479 | 15,278 | 3,205,307 | 3.2 M to 3.2 M (+0.05 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.32 | 448 | 4,623 | 3,203,828 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.31 | 200 | 2,062 | 3,203,380 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.30 | 300 | 3,090 | 3,203,180 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 11.00 | 2,017 | 22,187 | 3,202,880 | 3.2 M to 3.2 M (+0.06 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.99 | 500 | 5,495 | 3,200,863 | 3.2 M to 3.2 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.98 | 83 | 911 | 3,200,363 | 3.2 M to 3.2 M (0.00 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.97 | 1,092 | 11,979 | 3,200,280 | 3.2 M to 3.2 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.96 | 700 | 7,672 | 3,199,188 | 3.2 M to 3.2 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.95 | 308 | 3,373 | 3,198,488 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.94 | 1,000 | 10,940 | 3,198,180 | 3.2 M to 3.2 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.93 | 900 | 9,837 | 3,197,180 | 3.2 M to 3.2 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.92 | 1,700 | 18,564 | 3,196,280 | 3.2 M to 3.2 M (+0.05 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.91 | 2,310 | 25,202 | 3,194,580 | 3.2 M to 3.2 M (+0.07 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.90 | 1,290 | 14,061 | 3,192,270 | 3.2 M to 3.2 M (+0.04 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.89 | 1,400 | 15,246 | 3,190,980 | 3.2 M to 3.2 M (+0.04 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.88 | 500 | 5,440 | 3,189,580 | 3.2 M to 3.2 M (+0.02 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.87 | 1,000 | 10,870 | 3,189,880 | 3.2 M to 3.2 M (+0.03 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.86 | 200 | 2,172 | 3,188,080 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.85 | 400 | 4,340 | 3,187,880 | 3.2 M to 3.2 M (+0.01 %) |
Sep 05 2008 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 10.84 | 200 | 2,168 | 3,187,480 | 3.2 M to 3.2 M (+0.01 %) |